| |
| . |
 24  1/2  |
|
|
|
Subject |
Hyundai Pharm, Yeong Hak Kim appointed as a new President at the board meeting |
Content |
Hyundai Pharm, Yeong Hak Kim appointed as a new President at the board meeting
2013 Sales 106.6 Million USD. 5.4% YoY Growth
On Feb 13th, Hyundai Pharm (Fiscal Month: November) held the 50th Annual General Meeting of Shareholders at its Cheonan Factory conference room.
President, Chang Hyeon Yun stated as of last year, Hyundai’s sales grew to 106.6 Million USD (5.4% YoY), and its net profit had surplus of 1.3 Million USD; Hyundai, being selected as an innovative pharmaceutical company in 2012, was recognized externally of their innovation and excellence in R&D as attracting three national project in Korea.
On that day, Yeong Hak Kim was appointed as a new President who succeeded Yun Chang Hyeon, and Sang Joon Lee was re-elected as a director from the board meeting. |
Date |
2014-02-18 |
|
 |
 |
 |
|
